Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[222 Pages Report] The global oral controlled release drug delivery technology market is poised to grow from US$ 34.1 billion in 2022 to US$ 68.4 billion by 2032, with overall demand expected to surge at 7.2% CAGR throughout the forecast period (2022 to 2032). The rising incidence of chronic diseases coupled with a growing preference for oral drug delivery due to its various benefits is the key factor driving demand for oral controlled-release drug delivery technology.
Based on form, the solid dosage forms segment is expected to lead the global oral controlled release drug delivery technology market throughout the forecast period with an estimated share of nearly 87%.
Attribute | Key Statistics |
---|---|
Oral Controlled Release Drug Delivery Technology Market Base Value (2021) | US$ 31.8 billion |
Estimated Market Value (2022) | US$ 34.1 billion |
Projected Market Value (2032) | US$ 68.4 billion |
Value-based CAGR (2022 to 2032) | 7.2% |
Market share of Top 5 countries | 62.1% |
The oral controlled release drug delivery system is designed to deliver a drug in a controlled and predictable manner over a period of time or at a predetermined position in the gastrointestinal tract. Oral dosage forms are preferred for their convenience and cost-effectiveness.
Oral controlled release drug delivery technologies like, Geolock, Geomatrix, OROS (osmotic-controlled release drug delivery system), SODAS (Spheroidal oral drug absorption system), and many more are exclusively used for most of the pharmaceutical drug candidates and are the most common form to deliver medication to patients.
Oral solid dosage forms coupled with new drug releases mechanisms such as dissolution and diffusion-controlled drug release delivery systems are expected to remain a mainstay in the global pharmaceuticals market as these type of new and enhanced drug delivery systems with the use of advanced polymers tend to be an important part of drug development technology and approvals of new chemical entities.
The overall oral controlled release drug delivery technology market formed nearly 14% of the global pharmaceutical drug delivery market which was valued at around US$ 230 billion in 2021
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales in the oral controlled release drug delivery technology market are projected to rise at 7.2% CAGR during the forecast period between 2022 to 2032, in comparison to 6.5% CAGR registered from 2012 to 2021.
Growing demand for specialized oral dosage forms such as pediatric or geriatric tablets with controlled release drug delivery systems, the adoption rate of newly developed and innovative technologies such as nanotechnology, osmotically controlled release, hydrophilic ion exchange, etc. are the prime factors expected to drive the growth of oral controlled release drug delivery technology market over the forecast period.
Oral drug delivery has become the most preferred and convenient option as the oral route provides maximum active surface area among all drug delivery systems for the administration of various drugs.
Increasing generic penetration is another important factor pushing the growth of the global market. Oral solid dosage forms such as tablets and capsules represent the largest growth opportunity for generic players.
Some other factors influencing the growth of the global oral controlled release drug delivery technology market include cost-effective generic dosage forms, Research and Development (R&D) scientists, and healthcare professionals’ preference for sustained release controlled delivery coupled with new biopolymers embedded with advanced coating technology in solid dosage forms, liquids, and semisolids.
Furthermore, the combination of various technologies to overcome the limitations of poorly soluble substances/drugs/chemicals and the higher adoption rate of these combined products/technologies at convenient pricing is expected to boost the oral controlled release drug delivery technology market.
In addition to this, increasing approval of modified and extended-release oral dosage forms by various health ministries across the world is likely to drive the market.
The rise in Chronic Diseases and Advancement in Drug Delivery Techniques to Boost Market Growth
As per FMI, the global oral controlled release drug delivery technology market is projected to expand at a robust pace during the forecast period, owing to the rising prevalence of chronic and infectious diseases like cancer, T.B. heart disease, diabetes, etc., and increasing spending on oral medications.
Similarly, continuous efforts of manufacturers to develop and produce novel complex drug products with customized release trends will propel the expansion of the oral controlled release drug delivery technology market globally during the forecast years.
Use of combination techniques such as modified controlled release mechanisms and other platforms which uses ion exchange release (hydrophilic & hydrophobic), osmotically controlled release, diffusion & dissolution (combined) controlled release in new drug formulation procedures is on the rise across the healthcare industry and the trend is likely to continue during the forecast period.
Also, the introduction of super generics, continuous new technology launches, and a growing number of contract manufacturing facilities for oral solid dosage forms & liquid dosage forms, and enhanced patient compliance are expected to create lucrative market growth opportunities during the forecast period.
According to research published in the Journal of Controlled Release, it has been found that ‘casein’ based formulations are probable contenders for controlled release drug delivery systems, because of their properties like high tensile strength and presence of naturally occurring genipin, tissue enzyme & transglutaminase. Casein can also be used as a cross-linkers to prepare novel casein-based hydrogels for the controlled release of bioactive.
Similarly, the growing usage of 3D printing technology for designing and manufacturing oral formulations is expected to create lucrative opportunities for oral controlled-release drug delivery system manufacturers.
3D printing techniques can be used to produce multiple doses of drugs at a small scale and to improve drug formulations. 3D printing technology can be a great prospect for manufacturers to impose in their innovative, research and development department for drug formulations.
Formulation challenges are mainly drug-related - active pharmaceutical ingredients with a short half-life and the necessity for higher-dose delivery and formulation related, which regularly require dissolvable handling capacities in light of the fact that most polymers should be solubilized in natural solvents before covering the controlled-release formulations (i.e., tablets, granules, and capsules)
Growing research towards biological molecules and their dominance in treating oncology conditions are expected to hamper the growth of the oral controlled release drug delivery technology market over the forecast period.
According to an article published in Contract pharma, approximately 50% of the pipeline molecules are biologics and the rest are in the form of other dosage forms.
However, the low pipeline productivity of oral solids is the major factor hindering the growth of the oral controlled-release drug delivery technology market.
Other factors include a complex supply chain and stringent regulatory requirements, decreasing productivity coupled with low R&D expenditure, product related issues such as dose dumping and product recalls.
Rising Spending on Medicines Fuelling Market Growth in the USA
The USA oral controlled release drug delivery technology market reached a valuation of over US$ 11.0 billion in 2021 and is expected to grow over a CAGR of 7.0% during the forecast period (2022 to 2032).
The rising prevalence of chronic diseases such as cancer and diabetes, supporting initiatives & campaigns from the government, and investments in research & development are driving b growth in the USA market and the trend is likely to continue during the forecast period.
Similarly, the strong presence of major key players in the country and their promotional strategies for the adoption of controlled release drug delivery systems are expected to expand the oral controlled release drug delivery technology market in the future.
In addition to this, increasing spending on medicines across the country will create opportunities for oral controlled-release drug delivery technology manufacturers in the future. In fact, the USA is the highest spending country worldwide when it comes to health care.
According to the USA Department of Health and Human Services, USA prescription drug expenditures totaled an enormous valuation of US$370 billion in 2019 and this number is likely to further surge during the assessment period.
Rising Prevalence of Heart Diseases Driving Demand Across Germany
As of 2021, Germany held a revenue share of 21.5% of total European oral controlled release drug delivery technology market and it is estimated to grow at a healthy pace during the forecast period.
The German oral controlled release drug delivery technology market will likely be driven by improved patient compliance, rising geriatric and paediatric populations, and increased demand for controlled release drug delivery systems due to the prevalence of chronic diseases.
Over the years, there has been a sharp rise in cases of heart disease across Germany leading to a high death rate. Oral solid dosages are utilized very commonly for the treatment of the same. As per the World Health Organization (WHO) insights in 2019, nearly 37% of deaths in Germany were due to circulatory diseases.
Thus, the growing demand for oral solid dosage together with the rising prevalence of circulatory disease is expected to boost Germany’s oral controlled release drug delivery technology market during the next ten years.
Growing Preference for Oral Medication Fostering Market Growth in Japan
The overall oral controlled release drug delivery technology market in Japan reached US$ 2.6 billion in 2021 and it is expected to expand at a CAGR of around 6.7% during the forecast period. This can be attributed to the rising popularity of oral medication among the country’s rapidly growing population, advancements in the pharmaceutical sector, and increasing investments in R&D activities by biopharma companies.
Similarly, increasing healthcare spending and high levels of health awareness among the general public are expected to bolster the growth of the oral controlled release drug delivery technology market in Japan during the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Demand Remains High for Dissolution Controlled Release System
The dissolution controlled release system segment dominated the global oral controlled release drug delivery technology market with a revenue share of nearly 45% in 2021 and the trend is projected to continue throughout the forecast period.
Properties such as maximum efficacy with minimal side effects and reduced drug accumulation with drug level fluctuation are the major reasons for the adoption of this technique.
The dissolution controlled release system provides sustained release profiles i.e., In a dissolution controlled release system, the active drugs are released continuously at a slow rate to provide a long-term therapeutic effect. Thus, they provide a sustained release profile, which is encouraging their adoption across the world.
End Users Prefer Solid Dosage Forms
As per FMI, the solid dosage forms segment generated revenue of around US$ 27 billion in the global oral controlled release drug delivery technology market in 2021 and it is poised to grow at a higher CAGR over the next ten years. This can be attributed to the rising end-user preference for solid dosage forms.
Owing to the better physical and chemical stability, lower manufacturing costs, and easy-to-consume & carry features of solid dosage forms, it remains highly popular among end users. People are increasingly opting for solid dosage forms like tablets, capsules, and powders to treat various diseases.
Some of the key players identified in global oral controlled release drug delivery technology market are AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., and Johnson & Johnson.
These players are trying to combine new molecular entities with existing ones to explore clinical indications for controlled release mechanisms, which in turn is propelling the discovery of new matrix systems in the oral controlled release drug delivery technology market. Furthermore, they are partnering and collaborating with other companies to increase their revenue share. For instance,
Attribute | Details |
---|---|
Estimated Market Size (2022) | US$ 34.1 billion |
Projected Market Size (2032) | US$ 68.4 billion |
Anticipated Growth Rate (2022 to 2032) | 7.2% |
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2012 to 2021 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA). |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, the Rest of Latin America, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, the Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA. |
Key Market Segments Covered | Drug Release System, Dosage Form, Region |
Key Companies Profiled | AstraZeneca Plc., Bristol-Myers Squibb Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, GlaxoSmithKline Plc., Sun Pharmaceuticals, Sanofi S.A., Boehringer Ingelheim, AbbVie, Takeda, Eli Lilly, Bayer, Gilead Sciences, Amgen, BioNTech, Viatris, Moderna. |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
1. Executive Summary | Oral Controlled Release Drug Delivery Technology Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Key Success Factors 4.1. Disease Epidemiology, by Region 4.2. Key promotional strategies by manufacturers 4.3. Regulatory Landscape 4.4. Value chain analysis 4.5. Drug Release System adoption analysis 4.6. PESTEL Analysis 4.7. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increasing Complexity of Healthcare Operations 5.2.3. Drug Release System Pricing 5.2.4. Strategic Collaborations amongst Players 5.2.5. Rising Prevalence of Infections and Surgical Procedures 5.2.6. Adoption Rate 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID 002D19 and Impact Analysis 6.1.1. By Drug Release System 6.1.2. By Dosage Form 6.1.3. By Country 6.2. 2021 Market Scenario 7. Global Oral Controlled Release Drug Delivery Technology Market Demand (in Value) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ million) Analysis, 2012 to 2021 7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Drug Release System 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ million) Analysis, By Drug Release System, 2012 to 2021 8.3. Current and Future Market Size (US$ million) Analysis and Forecast, By Drug Release System, 2022 to 2032 8.3.1. Dissolution Controlled Release System 8.3.2. Diffusion Controlled Release System 8.3.3. Osmotically Controlled Release System 8.3.4. Dissolution & Diffusion Controlled Release System 8.3.5. Ion Exchange Resins Controlled Release 8.3.6. Hydrodynamically Balanced Drug Delivery System 8.3.7. Others 8.4. Market Attractiveness Analysis, by Drug Release System 9. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Dosage Form 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ million) Analysis, By Dosage Form, 2012 to 2021 9.3. Current and Future Market Size (US$ million) Analysis and Forecast, by Dosage Form, 2022 to 2032 9.3.1. Solid Dosage Form 9.3.2. Semisolid/Liquid/Suspensions 9.4. Market Attractiveness Analysis, by Dosage Form 10. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region 10.1. Introduction 10.2. Historical Market Size (US$ million) Analysis, by Region, 2012 to 2021 10.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis, by Region 11. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 11.1. Introduction 11.2. Historical Market Size (US$ million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 11.3. Current and Future Market Value (US$ million) and Volume (Unit) Projections, 2022 to 2032 11.3.1. By Country 11.3.1.1. The USA 11.3.1.2. Canada 11.3.2. By Drug Release System 11.3.3. By Dosage Form 11.3.4. By Distribution Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Drug Release System 11.4.3. By Dosage Form 11.5. Market Trends 11.6. Drivers and Restraints - Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. The USA Oral Controlled Release Drug Delivery Technology Market Analysis 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast, by Market Taxonomy 11.7.1.2.1. By Drug Release System 11.7.1.2.2. By Dosage Form 11.7.2. Canada Oral Controlled Release Drug Delivery Technology Market Analysis 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast, by Market Taxonomy 11.7.2.2.1. By Drug Release System 11.7.2.2.2. By Dosage Form 12. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 12.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 12.3.1. By Country 12.3.1.1. Mexico 12.3.1.2. Brazil 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Drug Release System 12.3.3. By Dosage Form 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Drug Release System 12.4.3. By Dosage Form 12.5. Market Trends 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Mexico Oral Controlled Release Drug Delivery Technology Market Analysis 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy 12.7.1.2.1. By Drug Release System 12.7.1.2.2. By Dosage Form 12.7.2. Brazil Oral Controlled Release Drug Delivery Technology Market Analysis 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy 12.7.2.2.1. By Drug Release System 12.7.2.2.2. By Dosage Form 12.7.3. Argentina Oral Controlled Release Drug Delivery Technology Market Analysis 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast, by Market Taxonomy 12.7.3.2.1. By Drug Release System 12.7.3.2.2. By Dosage Form 13. Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 13.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Italy 13.3.1.3. France 13.3.1.4. U.K. 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Drug Release System 13.3.3. By Dosage Form 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Drug Release System 13.4.3. By Dosage Form 13.5. Market Trends 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. Germany Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy 13.7.1.2.1. By Drug Release System 13.7.1.2.2. By Dosage Form 13.7.2. Italy Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy 13.7.2.2.1. By Drug Release System 13.7.2.2.2. By Dosage Form 13.7.3. France Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy 13.7.3.2.1. By Drug Release System 13.7.3.2.2. By Dosage Form 13.7.4. U.K. Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.4.1. Introduction 13.7.4.2. Market Analysis and Forecast, by Market Taxonomy 13.7.4.2.1. By Drug Release System 13.7.4.2.2. By Dosage Form 13.7.5. Spain Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.5.1. Introduction 13.7.5.2. Market Analysis and Forecast, by Market Taxonomy 13.7.5.2.1. By Drug Release System 13.7.5.2.2. By Dosage Form 13.7.6. BENELUX Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.6.1. Introduction 13.7.6.2. Market Analysis and Forecast, by Market Taxonomy 13.7.6.2.1. By Drug Release System 13.7.6.2.2. By Dosage Form 13.7.7. Russia Oral Controlled Release Drug Delivery Technology Market Analysis 13.7.7.1. Introduction 13.7.7.2. Market Analysis and Forecast, by Market Taxonomy 13.7.7.2.1. By Drug Release System 13.7.7.2.2. By Dosage Form 14. East Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Distribution Channel (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 14.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Drug Release System 14.3.3. By Dosage Form 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Drug Release System 14.4.3. By Dosage Form 14.5. Market Trends 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. China Oral Controlled Release Drug Delivery Technology Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy 14.7.1.2.1. By Drug Release System 14.7.1.2.2. By Dosage Form 14.7.2. Japan Oral Controlled Release Drug Delivery Technology Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy 14.7.2.2.1. By Drug Release System 14.7.2.2.2. By Dosage Form 14.7.3. South Korea Oral Controlled Release Drug Delivery Technology Market Analysis 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy 14.7.3.2.1. By Drug Release System 14.7.3.2.2. By Dosage Form 15. South Asia Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 15.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Indonesia 15.3.1.3. Malaysia 15.3.1.4. Thailand 15.3.1.5. Rest of South Asia 15.3.2. By Drug Release System 15.3.3. By Dosage Form 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Drug Release System 15.4.3. By Dosage Form 15.5. Market Trends 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. India Oral Controlled Release Drug Delivery Technology Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy 15.7.1.2.1. By Drug Release System 15.7.1.2.2. By Dosage Form 15.7.2. Indonesia Oral Controlled Release Drug Delivery Technology Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy 15.7.2.2.1. By Drug Release System 15.7.2.2.2. By Dosage Form 15.7.3. Malaysia Oral Controlled Release Drug Delivery Technology Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy 15.7.3.2.1. By Drug Release System 15.7.3.2.2. By Dosage Form 15.7.4. Thailand Oral Controlled Release Drug Delivery Technology Market Analysis 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast, by Market Taxonomy 15.7.4.2.1. By Drug Release System 15.7.4.2.2. By Dosage Form 16. Oceania Oral Controlled Release Drug Delivery Technology Market 2012-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Drug Release System 16.3.3. By Dosage Form 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Drug Release System 16.4.3. By Dosage Form 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. Australia Oral Controlled Release Drug Delivery Technology Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy 16.7.1.2.1. By Drug Release System 16.7.1.2.2. By Dosage Form 16.7.2. New Zealand Oral Controlled Release Drug Delivery Technology Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy 16.7.2.2.1. By Drug Release System 16.7.2.2.2. By Dosage Form 17. Middle East and Africa (MEA) Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ million) Trend Analysis, by Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Value (US$ million) Projections, 2022 to 2032 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. South Africa 17.3.1.4. Israel 17.3.1.5. North Africa 17.3.1.6. Rest of Middle East and Africa 17.3.2. By Drug Release System 17.3.3. By Dosage Form 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Drug Release System 17.4.3. By Dosage Form 17.5. Market Trends 17.6. Drivers and Restraints - Impact Analysis 17.7. Country-Level Analysis & Forecast 17.7.1. GCC Countries Oral Controlled Release Drug Delivery Technology Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy 17.7.1.2.1. By Drug Release System 17.7.1.2.2. By Dosage Form 17.7.2. Turkey Oral Controlled Release Drug Delivery Technology Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy 17.7.2.2.1. By Drug Release System 17.7.2.2.2. By Dosage Form 17.7.3. South Africa Oral Controlled Release Drug Delivery Technology Market Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy 17.7.3.2.1. By Drug Release System 17.7.3.2.2. By Dosage Form 17.7.4. Israel Oral Controlled Release Drug Delivery Technology Market Analysis 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast, by Market Taxonomy 17.7.4.2.1. By Drug Release System 17.7.4.2.2. By Dosage Form 17.7.5. North Africa Oral Controlled Release Drug Delivery Technology Market 17.7.5.1. Introduction 17.7.5.2. Market Analysis and Forecast, by Market Taxonomy 17.7.5.2.1. By Drug Release System 17.7.5.2.2. By Dosage Form 18. Market Structure Analysis 18.1. Market Analysis, by Tier of Companies 18.2. Market Share Analysis of Top Players 18.3. Market Presence Analysis 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. AstraZeneca Plc. 19.3.1.1. Overview 19.3.1.2. Drug Release System Portfolio 19.3.1.3. Profitability by Market Segments (Product/Channel/Region) 19.3.1.4. Sales Footprint 19.3.1.5. Key Financials 19.3.1.6. SWOT Analysis 19.3.1.7. Strategy Overview 19.3.2. Bristol-Myers Squibb Company 19.3.2.1. Overview 19.3.2.2. Drug Release System Portfolio 19.3.2.3. Profitability by Market Segments (Product/Channel/Region) 19.3.2.4. Sales Footprint 19.3.2.5. Key Financials 19.3.2.6. SWOT Analysis 19.3.2.7. Strategy Overview 19.3.3. Merck & Co. Inc. 19.3.3.1. Overview 19.3.3.2. Drug Release System Portfolio 19.3.3.3. Profitability by Market Segments (Product/Channel/Region) 19.3.3.4. Sales Footprint 19.3.3.5. Key Financials 19.3.3.6. SWOT Analysis 19.3.3.7. Strategy Overview 19.3.4. Novartis AG 19.3.4.1. Overview 19.3.4.2. Drug Release System Portfolio 19.3.4.3. Profitability by Market Segments (Product/Channel/Region) 19.3.4.4. Sales Footprint 19.3.4.5. Key Financials 19.3.4.6. SWOT Analysis 19.3.4.7. Strategy Overview 19.3.5. Pfizer Inc. 19.3.5.1. Overview 19.3.5.2. Drug Release System Portfolio 19.3.5.3. Profitability by Market Segments (Product/Channel/Region) 19.3.5.4. Sales Footprint 19.3.5.5. Key Financials 19.3.5.6. SWOT Analysis 19.3.5.7. Strategy Overview 19.3.6. F. Hoffman-La-Roche Ltd. 19.3.6.1. Overview 19.3.6.2. Drug Release System Portfolio 19.3.6.3. Profitability by Market Segments (Product/Channel/Region) 19.3.6.4. Sales Footprint 19.3.6.5. Key Financials 19.3.6.6. SWOT Analysis 19.3.6.7. Strategy Overview 19.3.7. Johnson & Johnson 19.3.7.1. Overview 19.3.7.2. Drug Release System Portfolio 19.3.7.3. Profitability by Market Segments (Product/Channel/Region) 19.3.7.4. Sales Footprint 19.3.7.5. Key Financials 19.3.7.6. SWOT Analysis 19.3.7.7. Strategy Overview 19.3.8. GlaxoSmithKline Plc. 19.3.8.1. Overview 19.3.8.2. Drug Release System Portfolio 19.3.8.3. Profitability by Market Segments (Product/Channel/Region) 19.3.8.4. Sales Footprint 19.3.8.5. Key Financials 19.3.8.6. SWOT Analysis 19.3.8.7. Strategy Overview 19.3.9. Sun Pharmaceuticals 19.3.9.1. Overview 19.3.9.2. Drug Release System Portfolio 19.3.9.3. Profitability by Market Segments (Product/Channel/Region) 19.3.9.4. Sales Footprint 19.3.9.5. Key Financials 19.3.9.6. SWOT Analysis 19.3.9.7. Strategy Overview 19.3.10. Sanofi S.A. 19.3.10.1. Overview 19.3.10.2. Drug Release System Portfolio 19.3.10.3. Profitability by Market Segments (Product/Channel/Region) 19.3.10.4. Sales Footprint 19.3.10.5. Key Financials 19.3.10.6. SWOT Analysis 19.3.10.7. Strategy Overview 19.3.11. Boehringer Ingelheim 19.3.11.1. Overview 19.3.11.2. Drug Release System Portfolio 19.3.11.3. Profitability by Market Segments (Product/Channel/Region) 19.3.11.4. Sales Footprint 19.3.11.5. Key Financials 19.3.11.6. SWOT Analysis 19.3.11.7. Strategy Overview 19.3.12. AbbVie 19.3.12.1. Overview 19.3.12.2. Drug Release System Portfolio 19.3.12.3. Profitability by Market Segments (Product/Channel/Region) 19.3.12.4. Sales Footprint 19.3.12.5. Key Financials 19.3.12.6. SWOT Analysis 19.3.12.7. Strategy Overview 19.3.13. Takeda 19.3.13.1. Overview 19.3.13.2. Drug Release System Portfolio 19.3.13.3. Profitability by Market Segments (Product/Channel/Region) 19.3.13.4. Sales Footprint 19.3.13.5. Key Financials 19.3.13.6. SWOT Analysis 19.3.13.7. Strategy Overview 19.3.14. Eli Lilly 19.3.14.1. Overview 19.3.14.2. Drug Release System Portfolio 19.3.14.3. Profitability by Market Segments (Product/Channel/Region) 19.3.14.4. Sales Footprint 19.3.14.5. Key Financials 19.3.14.6. SWOT Analysis 19.3.14.7. Strategy Overview 19.3.15. Bayer 19.3.15.1. Overview 19.3.15.2. Drug Release System Portfolio 19.3.15.3. Profitability by Market Segments (Product/Channel/Region) 19.3.15.4. Sales Footprint 19.3.15.5. Key Financials 19.3.15.6. SWOT Analysis 19.3.15.7. Strategy Overview 19.3.16. Gilead Sciences 19.3.16.1. Overview 19.3.16.2. Drug Release System Portfolio 19.3.16.3. Profitability by Market Segments (Product/Channel/Region) 19.3.16.4. Sales Footprint 19.3.16.5. Key Financials 19.3.16.6. SWOT Analysis 19.3.16.7. Strategy Overview 19.3.17. Amgen 19.3.17.1. Overview 19.3.17.2. Drug Release System Portfolio 19.3.17.3. Profitability by Market Segments (Product/Channel/Region) 19.3.17.4. Sales Footprint 19.3.17.5. Key Financials 19.3.17.6. SWOT Analysis 19.3.17.7. Strategy Overview 19.3.18. BioNTech 19.3.18.1. Overview 19.3.18.2. Drug Release System Portfolio 19.3.18.3. Profitability by Market Segments (Product/Channel/Region) 19.3.18.4. Sales Footprint 19.3.18.5. Key Financials 19.3.18.6. SWOT Analysis 19.3.18.7. Strategy Overview 19.3.19. Viatris 19.3.19.1. Overview 19.3.19.2. Drug Release System Portfolio 19.3.19.3. Profitability by Market Segments (Product/Channel/Region) 19.3.19.4. Sales Footprint 19.3.19.5. Key Financials 19.3.19.6. SWOT Analysis 19.3.19.7. Strategy Overview 19.3.20. Moderna 19.3.20.1. Overview 19.3.20.2. Drug Release System Portfolio 19.3.20.3. Profitability by Market Segments (Product/Channel/Region) 19.3.20.4. Sales Footprint 19.3.20.5. Key Financials 19.3.20.6. SWOT Analysis 19.3.20.7. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 02: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 03: Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 by Region Table 04: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 05: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 06: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 07: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 08: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 09: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 10: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 11: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 12: Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 13: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 14: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 15: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 16: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 17: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 18: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form Table 19: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 20: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 21: Oceania Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032By Dosage Form Table 22: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 by Country Table 23: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 and Forecast 2022 to 2032 By Drug Release System Table 24: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012 to 2021 and Forecast 2022 to 2032 By Dosage Form
Figure 01: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 02: Global Oral Controlled Release Drug Delivery Technology Market Forecast & Y-o-Y Growth 2022 to 2032 Figure 03: Global Oral Controlled Release Drug Delivery Technology Market Absolute $ Opportunity (US$ million) Analysis 2021 to 2032 Figure 04: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Drug Release System Figure 05: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 By Drug Release System Figure 06: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 By Drug Release System Figure 07: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 By Dosage Form Figure 08: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 By Dosage Form Figure 09: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 By Dosage Form Figure 10: Global Oral Controlled Release Drug Delivery Technology Market Value Share (%) Analysis 2022 and 2032 by Region Figure 11: Global Oral Controlled Release Drug Delivery Technology Market Y-o-Y Growth (%) Analysis 2022 to 2032 by Region Figure 12: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis 2022 to 2032 by Region Figure 13: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 14: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 15: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 16: North America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 17: North America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 18: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 19: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 20: USA Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 21: Global Vs. USA Growth Comparison 2022 to 2032 Figure 22: USA Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 23: U.S. Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 24: Canada Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 25: Global Vs. Canada. Growth Comparison 2022 to 2032 Figure 26: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 27: Canada Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 28: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 29: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 30: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 31: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 32: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 33: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 34: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 35: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 36: Mexico Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 37: Global Vs Mexico Growth Comparison 2022 to 2032 Figure 38: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 39: Mexico Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 40: Brazil Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 41: Global Vs. Brazil. Growth Comparison 2022 to 2032 Figure 42: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 43: Brazil Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 44: Argentina Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 45: Global Vs Argentina Growth Comparison 2022 to 2032 Figure 46: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 47: Argentina Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 48: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 49: Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 50: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 51: Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 52: Europe Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 53: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 54: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 55: Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 56: UK Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 57: Global Vs. UK Growth Comparison 2022 to 2032 Figure 58: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 59: UK Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 60: Germany Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 61: Global Vs. Germany Growth Comparison 2022 to 2032 Figure 62: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 63: Germany Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 64: Italy Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 65: Global Vs. Italy Growth Comparison 2022 to 2032 Figure 66: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 67: Italy Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 68: France Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 69: Global Vs France Growth Comparison 2022 to 2032 Figure 70: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 71: France Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 72: Spain Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 73: Global Vs Spain Growth Comparison 2022 to 2032 Figure 74: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 75: Spain Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 76: Russia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 77: Global Vs Russia Growth Comparison 2022 to 2032 Figure 78: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 79: Russia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 80: BENELUX Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 81: Global Vs BENELUX Growth Comparison 2022 to 2032 Figure 82: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 83: BENELUX Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 84: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 85: East Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 86: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 87: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 88: East Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 89: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 90: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 91: East Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 92: China Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 93: Global Vs. China Growth Comparison 2022 to 2032 Figure 94: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 95: China Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 96: Japan Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 97: Global Vs. Japan Growth Comparison 2022 to 2032 Figure 98: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 99: Japan Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 100: South Korea Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 101: Global Vs South Korea Growth Comparison 2022 to 2032 Figure 102: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 103: South Korea Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 104: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 105: South Asia Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 106: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 107: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 108: South Asia Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 109: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 110: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 111: South Asia Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 112: India Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 113: Global Vs. India Growth Comparison 2022 to 2032 Figure 114: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 115: India Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 116: Indonesia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 117: Global Vs. Indonesia Growth Comparison 2022 to 2032 Figure 118: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 119: Indonesia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 120: Malaysia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 121: Global Vs. Malaysia Growth Comparison 2022 to 2032 Figure 122: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 123: Malaysia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 124: Thailand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 125: Global Vs. Thailand Growth Comparison 2022 to 2032 Figure 126: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 127: Thailand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 128: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 129: Oceania Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 130: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 131: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 132: Oceania Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 133: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 134: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 135: Oceania Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 136: Australia Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 137: Global Vs. Australia Growth Comparison 2022 to 2032 Figure 138: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 139: Australia Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 140: New Zealand Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 141: Global Vs New Zealand Growth Comparison 2022 to 2032 Figure 142: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 143: New Zealand Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 144: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Analysis 2012 to 2021 Figure 145: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value (US$ million) Forecast 2022 to 2032 Figure 146: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2022 E) Figure 147: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share By Dosage Form (2022 E) Figure 148: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Value Share by Country (2022 E) Figure 149: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System 2022 to 2032 Figure 150: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form 2022 to 2032 Figure 151: Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis by Country 2022 to 2032 Figure 152: GCC Countries Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 153: Global Vs GCC Countries Growth Comparison 2022 to 2032 Figure 154: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 155: GCC Countries Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 156: Turkey Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 157: Global Vs. Turkey Growth Comparison 2022 to 2032 Figure 158: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 159: Turkey Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 160: South Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 161: Global Vs. South Africa Growth Comparison 2022 to 2032 Figure 162: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 163: South Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032 Figure 164: North Africa Oral Controlled Release Drug Delivery Technology Market Value Proportion Analysis 2021 Figure 165: Global Vs North Africa Growth Comparison 2022 to 2032 Figure 166: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Drug Release System 2021 to 2032 Figure 167: North Africa Oral Controlled Release Drug Delivery Technology Market Share Analysis (%) By Dosage Form 2021 to 2032
Recommendations
Explore Healthcare Insights
View Reports